Comparison of TB+PB and TB+6SB for Prostate Cancer Diagnosis
NCT07460843 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 592
Last updated 2026-03-12
Summary
The goal of this randomized controlled trial (RCT) is to evaluate the diagnostic efficacy of two novel prostate biopsy schemes, including targeted and perilesional biopsy (TB+PB) and combination of sextant-systematic biopsy and targeted biopsy (TB+6SB).
The main questions it aims to answer are:
Does TB+PB promote the accurate diagnosis of clinically significant prostate cancer (csPCa)? Could TB+6SB achieve the non-inferior diagnostic efficacy compared to TB+PB scheme? What's the value of TB+6SB in improving the detection of prostate cancer in the negative prostate lobe (contralateral to the index lesion)? In the era of MRI-targeted biopsy (TB), when TB and PB is effectively conducted and allows confident detection of the ROI, do we still need to perform SB? Researchers will compare the cancer detection rates of TB+PB and TB+SB to explore the efficacy of different prostate biopsy schemes. They will evaluate the diagnostic profile of different prostate biopsy schemes through the spatial analysis of the prostate.
Participants will:
Receive TB+PB or TB+6SB.
Conditions
- Prostate Cancer (Diagnosis)
Interventions
- PROCEDURE
-
TB+PB
The biopsy procedure was conducted by a highly skilled and experienced urologist who specializes in performing prostate biopsies. Prophylactic antibiotics were routinely used both before and one day prior to scheduled surgery. Each patient was placed in the left lateral position or lithotomy position. The ultrasound equipment used included a color Doppler ultrasound diagnostic instrument (Hitachi HiVision, Philips Epiq 7), transrectal probes, and corresponding puncture needle guns. Color Doppler examination was performed from the base to the apex. For patients in the TB+PB group, three-core TB was obtained within the predefined MRI suspicious lesion (ROI), followed by ring-distributed 6-core PB within a 10 to 15 mm radius around the ROI. The location of these nine cores depended on the shape and location of the suspicious lesion. Each core was placed in an individual container and reported separately in accordance with the Ginsburg scheme.
- PROCEDURE
-
TB+6SB
The biopsy procedure was conducted by a highly skilled and experienced urologist who specializes in performing prostate biopsies. Prophylactic antibiotics were routinely used both before and one day prior to scheduled surgery. Each patient was placed in the left lateral position or lithotomy position. The ultrasound equipment used included a color Doppler ultrasound diagnostic instrument (Hitachi HiVision, Philips Epiq 7), transrectal probes, and corresponding puncture needle guns. Color Doppler examination was performed from the base to the apex. For patients in the TB+6SB group, three-core TB within the predefined mpMRI index lesion (ROI) was firstly performed. Then patients received six-core sextant-SB bilaterally with each side two cores in the peripheral zone and one core in the transitional zone. Each core was placed in an individual container and reported separately in accordance with the Ginsburg scheme.
Sponsors & Collaborators
-
Peking University First Hospital
lead OTHER
Principal Investigators
-
Yi Liu · Peking University First Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-03-01
- Primary Completion
- 2026-12-31
- Completion
- 2027-03-31
Countries
- China
Study Locations
More Related Trials
-
The Accuracy of Modified TTMB in the Spatial Distribution of Prostate Cancer
NCT03418207 ·Status: UNKNOWN ·Phase: NA
-
Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and Complications
NCT04081636 ·Status: COMPLETED ·Phase: NA
-
Comparison of MRI AI-cTB Versus Routine cTB in Prostate Cancer Diagnosis: a Prospective Randomized Controlled Trial
NCT06362291 ·Status: COMPLETED ·Phase: NA
-
MR-targeted vs. Random TRUS-guided Prostate Biopsy
NCT02678481 ·Status: UNKNOWN ·Phase: NA
-
Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer Detection
NCT03572946 ·Status: UNKNOWN ·Phase: NA
-
Ultrasound Based Transperineal Robotic Biopsy of the the Prostate
NCT01102361 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Diagnostic Value of MRI-targeted Plus Index-lesion-ipsilaterally Systematic Biopsy for Biopsy-naive Men At Risk of Prostate Cancer
NCT06584279 ·Status: RECRUITING
-
Micro-ultrasound for Prostate Cancer Diagnosis
NCT04832997 ·Status: TERMINATED ·Phase: NA
-
PSMA PET/MRI-Guided Prostate Biopsy for PI-RADS ≤3 and Prior Negative Biopsy
NCT06923657 ·Status: RECRUITING ·Phase: NA
-
Comparison of MRI Artificial Intelligence-guided cTB Versus Routine cTB in Prostate Cancer Diagnosis
NCT06392737 ·Status: RECRUITING ·Phase: NA
-
Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy
NCT02597894 ·Status: WITHDRAWN ·Phase: NA
-
A Diagnostic Prediction Model for Prostate Cancer in Patients With PI-RADS Score 3
NCT06507462 ·Status: COMPLETED
-
Whether Transperineal Prostate Biopsy Under Local-anaesthesia Using a Transperineal-access System is Non-inferior to Standard Transrectal Biopsy to Detect Prostate Cancer in Biopsy-naïve Men
NCT04108871 ·Status: UNKNOWN ·Phase: NA
-
Cancer Diagnosis by Multiparametric UltraSound of the Prostate
NCT02712684 ·Status: UNKNOWN
-
A Prospective, Randomized Trial Comparing Office-based MR-guided Prostate Biopsy Approaches
NCT03632655 ·Status: TERMINATED ·Phase: NA
-
Use of Multi-Parametric MRI With Prostate Biopsy for Cancer Diagnosis.
NCT01964638 ·Status: COMPLETED ·Phase: NA
-
Multi-parametric Ultrasound Versus Multi-parametric MRI for Prostate Cancer Detection
NCT06183905 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prospective Comparison of the Four Biopsy Methods for Prostate Cancer Detection
NCT05589558 ·Status: COMPLETED ·Phase: NA
-
Comparing pOrtable MRI and TRUS-Fusion Prostate Biopsy to Assess aCcuracy of Prostate Cancer Detection
NCT06453785 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Transperineal Versus Transrectal Prostate Biopsy
NCT06027203 ·Status: COMPLETED
-
Randomized Controlled Trial of MRI Target Biopsy: Transrectal vs. Transperineal
NCT03650153 ·Status: COMPLETED ·Phase: NA
-
The Value of Dual-parametric Magnetic Resonance Combined With Regional Saturation Biopsy in Patients With Suspected Prostate Cancer
NCT06824259 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Combining High-frequency Micro-ultrasound and Multiparametric MRI Target Biopsy for Detecting Prostate Cancer
NCT06579911 ·Status: RECRUITING ·Phase: NA
-
Decade-Long Insights Into Transperineal Prostate Biopsy in a West China Population
NCT06366308 ·Status: NOT_YET_RECRUITING
-
Transperineal, MRI-guided, Prostate Biopsy
NCT02651948 ·Status: COMPLETED ·Phase: PHASE4